These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 39083882)

  • 1. Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma: An addition for existing risk classification systems?
    van der Laan P; van der Graaf WTA; van den Broek D; van Boven H; Heeres BC; Schrage Y; Haas RL; Steeghs N; van Houdt WJ
    Eur J Surg Oncol; 2024 Sep; 50(9):108530. PubMed ID: 39083882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma.
    Choi ES; Kim HS; Han I
    Ann Surg Oncol; 2014 Mar; 21(3):778-85. PubMed ID: 24306668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative and Postoperative Platelet-Lymphocyte Ratio Is a Prognostic Marker for Patients With Soft Tissue Sarcoma Treated With Curative Resection.
    Lee IH; Na J; Lee SJ
    In Vivo; 2024; 38(4):2049-2057. PubMed ID: 38936914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
    Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
    Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
    J Surg Oncol; 2013 Dec; 108(7):481-5. PubMed ID: 24018883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
    Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
    Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the modified Glasgow Prognostic Score aid in the management of patients undergoing surgery for a soft-tissue sarcoma? : an international multicentre study.
    Spence S; Doonan J; Farhan-Alanie OM; Chan CD; Tong D; Cho HS; Sahu MA; Traub F; Gupta S;
    Bone Joint J; 2022 Jan; 104-B(1):168-176. PubMed ID: 34969280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
    Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
    Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
    Erdogan B; Kostek O; Bekir Hacioglu M; Gokyer A; Kucukarda A; Ozcan E; Gokmen I; Uzunoglu S; Cicin I
    J BUON; 2021; 26(5):2196-2201. PubMed ID: 34761635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Trabectedin Efficacy in Soft Tissue Sarcoma: Inflammatory Biomarker Analysis.
    Imai T; Kojima Y; Shimoi T; Aiba H; Okuma HS; Saito A; Kita S; Yamamoto K; Maejima A; Nishikawa T; Sudo K; Noguchi E; Yoshida A; Matsui Y; Iwata S; Kobayashi E; Kawai A; Udagawa R; Fujiwara Y; Yonemori K
    Anticancer Res; 2024 May; 44(5):2125-2132. PubMed ID: 38677749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas.
    Viñal D; Martinez D; Garcia-Cuesta JA; Gutierrez-Sainz L; Martinez-Recio S; Villamayor J; Martinez-Marin V; Gallego A; Ortiz-Cruz E; Mendiola M; Pozo-Kreilinger JJ; Berjon A; Belinchon B; Bernabeu D; Espinosa E; Feliu J; Redondo A
    Clin Transl Oncol; 2020 Oct; 22(10):1849-1856. PubMed ID: 32125644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
    Strong EA; Park SH; Ethun CG; Chow B; King D; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Gamblin TC; Cardona K; Clarke CN
    Surgery; 2020 Oct; 168(4):760-767. PubMed ID: 32736869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.
    Nakamura T; Matsumine A; Matsubara T; Asanuma K; Yada Y; Hagi T; Sudo A
    PLoS One; 2017; 12(7):e0181787. PubMed ID: 28727824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.
    Kobayashi H; Okuma T; Oka H; Hirai T; Ohki T; Ikegami M; Sawada R; Shinoda Y; Akiyama T; Sato K; Abe S; Kawano H; Goto T; Tanaka S
    Int J Clin Oncol; 2018 Apr; 23(2):368-374. PubMed ID: 29086877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and survival in undifferentiated pleomorphic sarcoma (NLR, PLR, and overall survival in UPS).
    Tepper SC; Lee L; Fice MP; Jones CM; Klein ED; Vijayakumar G; Batus M; Colman MW; Gitelis S; Blank AT
    Surg Oncol; 2023 Aug; 49():101949. PubMed ID: 37263041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Inflammation Is Associated with Oncological Outcome in Patients with High-Grade Myxofibrosarcoma of the Extremities: A Retrospective Analysis.
    Sambri A; Zucchini R; Giannini C; Cevolani L; Fiore M; Spinnato P; Bianchi G; Donati DM; De Paolis M
    Oncol Res Treat; 2020; 43(10):531-538. PubMed ID: 32810863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
    Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
    J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is a useful marker for predicting survival in patients with high-grade soft tissue sarcoma who have non-inflammatory conditions?
    Nakamura T; Asanuma K; Hagi T; Sudo A
    J Orthop Sci; 2024 Jul; 29(4):1125-1129. PubMed ID: 37537113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.